Skip to main content

Table 2 Comparison of neuropathy presence and laboratory data in patients with type 2 DM

From: Relationship between glycemic control and histochemical myeloperoxidase activity in neutrophils in patients with type 2 diabetes

 

With neuropathy

(n = 27)

Without neuropathy

(n = 43)

Controls

(n = 31)

p

MPO (%)

75 (50–86)a

80 (70–90)

87 (79.5–90.5)

0.011b

HBA1C (%)

9 (6.9–12.3)c

6.75 (5.6–9.75)

5.4 (5.08–5.5)

<0.001b

Sedimentation (mm/h)

43.96 ± 21.89d

32.87 ± 20.16

31.05 ± 16.27

0.036e

C-reactive protein (g/dl)

4.1 (2.39–8.87)d

1.95 (0.83–3.88)

1.37 (0.93–4.45)

0.002b

  1. aThe group with neuropathy and the control group are different from each other
  2. bIt was used the Kruskal–Wallis test for statistical analysis
  3. cAll groups are different from each other
  4. dThe group with neuropathy is different from other groups
  5. eIt was used the ANOVA test for statistical analysis